欢迎光临源叶生物,登录 | 注册 |
当前位置: 首页 > 小分子化合物 > 小分子抑制剂 > Acelarin

商品分类

浏览历史

S86665

Acelarin

源叶(MedMol) 99%
  • 英文名:
  • Acelarin
  • 别名:
  • CAS号:
  • 840506-29-8
  • 分子式:
  • C25H27F2N4O8P
  • 分子量:
  • 580.4744484
品牌货号产品规格价格(RMB) 库存(上海) 北京 武汉 南京 数量计量单位 加入购物车...
源叶(MedMol) S86665-5mg 99% ¥720.00元 预计交期:2-3天 0 0 0 EA 加入购物车
源叶(MedMol) S86665-10mg 99% ¥1430.00元 预计交期:2-3天 0 0 0 EA 加入购物车
源叶(MedMol) S86665-25mg 99% ¥2360.00元 预计交期:2-3天 0 0 0 EA 加入购物车
源叶(MedMol) S86665-50mg 99% ¥4700.00元 预计交期:2-3天 0 0 0 EA 加入购物车
源叶(MedMol) S86665-100mg 99% ¥5300.00元 预计交期:2-3天 0 0 0 EA 加入购物车
大包装询价

提交您的电话号码并同意《个人信息授权与保护申明》,到货后将短信提示。
提交

产品介绍

参考文献

质检证书(COA)

摩尔浓度计算器

相关产品

  • 提示:详情请下载说明书。
  • 产品描述: Acelarin (NUC-1031) is a ProTide transformation and enhancement of the widely-used nucleoside analogue, gemcitabine.
  • 靶点: EC50:0.2 nM (DNA synthesis inhibitor)
  • 体外研究: Gemcitabine is a nucleoside analogue commonly used in cancer therapy but with limited efficacy due to a high susceptibility to cancer cell resistance. The addition of a phosphoramidate motif to the gemcitabine can protect it against many of the key cancer resistance mechanisms. A series of gemcitabine phosphoramidate prodrugs are synthesized and screened for cytostatic activity in a range of different tumor cell lines. Among the synthesized compounds, NUC-1031 is shown to be potent in vitro.
  • 体内研究: The ProTide demonstrates a significant reduction in tumor size against pancreatic xenograft models compared with the gemcitabine treated group, and less adverse effects on body weight, indicating a better safety profile. Data strongly suggests that the ProTides are not reliant on kinases or nucleoside transporters to exert their activity inside tumor cells and remain stable in the presence of deaminases. The ProTide NUC-1031 is currently advancing through phase I/II clinical studies and has already generated strong pharmacokinetic data that confirm significantly higher intracellular levels of gemcitabine triphosphate, together with promising early efficacy signals and a favorable safety profile. The phosphoramidate chemistry is potentially a great source of new and very effective anticancer agents, bringing a considerable array of advanced treatments specifically designed to overcome cancer resistance mechanisms that will benefit a greater proportion of patients
  • 参考文献:
    1. Slusarczyk M, et al. Application of ProTide technology to gemcitabine: a successful approach to overcome the key cancer resistance mechanisms leads to a new agent (NUC-1031) in clinical development. J Med Chem. 2014 Feb 27;57(4):1531-42.
  • 溶解性: soluble  in  DMSO
  • 保存条件: -20℃
  • 配置溶液浓度参考:
    1mg 5mg 10mg
    1 mM 1.723 ml 8.614 ml 17.227 ml
    5 mM 0.345 ml 1.723 ml 3.445 ml
    10 mM 0.172 ml 0.861 ml 1.723 ml
    50 mM 0.034 ml 0.172 ml 0.345 ml
  • 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:


质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子量 (g/mol)


  • =
    *
    *


源叶所有产品仅用作科学研究,销售产品行为均适用于我司网上所列通用销售条款。